Apixaban Failure in A Post-Bariatric Surgery Female Patient with Thoracic Aortic Thrombus Secondary to Covid-19.

Q3 Medicine
European journal of case reports in internal medicine Pub Date : 2025-03-19 eCollection Date: 2025-01-01 DOI:10.12890/2025_005254
Joshua Hermiz, Nikolas Kenaya, Quang Dat Ha, Masahiro Yabe, Umesh Bhagat, Christian Toquica Gahona
{"title":"Apixaban Failure in A Post-Bariatric Surgery Female Patient with Thoracic Aortic Thrombus Secondary to Covid-19.","authors":"Joshua Hermiz, Nikolas Kenaya, Quang Dat Ha, Masahiro Yabe, Umesh Bhagat, Christian Toquica Gahona","doi":"10.12890/2025_005254","DOIUrl":null,"url":null,"abstract":"<p><p>A floating thrombus in the thoracic aorta represents a rare vascular condition frequently associated with morbidity and mortality. There is no standardised management approach, but options potentially include anticoagulation therapy, surgical intervention or a combination of these. Clinicians are increasingly selecting direct oral anticoagulants (DOACs) due to predictable pharmacokinetics. Here, we present a 37-year-old female with a history of Roux-en-Y gastric bypass surgery for obesity, who was found to have an incidental floating thrombus in the thoracic aorta during evaluation for generalised weakness and altered mentation following a recent COVID-19 infection. The patient was initially treated with intravenous heparin and subsequently transitioned to apixaban. Despite medication adherence, she presented two weeks later with worsening mental status and bilateral leg swelling. Repeat imaging revealed rupture of the thrombus, leading to right renal and bowel infarctions. The failure of anticoagulation was attributed to malabsorption secondary to her bariatric surgery. Despite aggressive interventions, the patient ultimately developed multisystem organ failure and succumbed to her illness. Literature suggests that DOACs may be less effective in post-bariatric patients due to altered pharmacokinetics. Due to the absence of clinical guidelines for post-bariatric patients, we recommend full-dose anticoagulation with warfarin, a vitamin K antagonist, to enable therapeutic international normalised ratio (INR) monitoring and necessary dose adjustments. DOACs are less effective in this population, particularly in hypercoagulable states, and the lack of monitoring increases the risk of treatment failure and subsequent life-threatening complications. This case report is of apixaban treatment failure in a female patient with a Roux-en-Y gastric bypass.</p><p><strong>Learning points: </strong>There is no established management of floating aortic mural thrombus detected by computed tomography.The efficacy of oral anticoagulants after bariatric surgery is uncertain.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"12 4","pages":"005254"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013231/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2025_005254","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A floating thrombus in the thoracic aorta represents a rare vascular condition frequently associated with morbidity and mortality. There is no standardised management approach, but options potentially include anticoagulation therapy, surgical intervention or a combination of these. Clinicians are increasingly selecting direct oral anticoagulants (DOACs) due to predictable pharmacokinetics. Here, we present a 37-year-old female with a history of Roux-en-Y gastric bypass surgery for obesity, who was found to have an incidental floating thrombus in the thoracic aorta during evaluation for generalised weakness and altered mentation following a recent COVID-19 infection. The patient was initially treated with intravenous heparin and subsequently transitioned to apixaban. Despite medication adherence, she presented two weeks later with worsening mental status and bilateral leg swelling. Repeat imaging revealed rupture of the thrombus, leading to right renal and bowel infarctions. The failure of anticoagulation was attributed to malabsorption secondary to her bariatric surgery. Despite aggressive interventions, the patient ultimately developed multisystem organ failure and succumbed to her illness. Literature suggests that DOACs may be less effective in post-bariatric patients due to altered pharmacokinetics. Due to the absence of clinical guidelines for post-bariatric patients, we recommend full-dose anticoagulation with warfarin, a vitamin K antagonist, to enable therapeutic international normalised ratio (INR) monitoring and necessary dose adjustments. DOACs are less effective in this population, particularly in hypercoagulable states, and the lack of monitoring increases the risk of treatment failure and subsequent life-threatening complications. This case report is of apixaban treatment failure in a female patient with a Roux-en-Y gastric bypass.

Learning points: There is no established management of floating aortic mural thrombus detected by computed tomography.The efficacy of oral anticoagulants after bariatric surgery is uncertain.

阿哌沙班治疗新冠肺炎继发性胸主动脉血栓女性减肥手术后失效
胸主动脉漂浮血栓是一种罕见的血管疾病,通常与发病率和死亡率相关。目前还没有标准化的治疗方法,但可能的选择包括抗凝治疗、手术干预或这些方法的结合。由于可预测的药代动力学,临床医生越来越多地选择直接口服抗凝剂(DOACs)。在这里,我们报告了一名37岁的女性,她因肥胖而接受过Roux-en-Y胃旁路手术,在最近感染COVID-19后的全身虚弱和精神状态改变评估中,发现胸主动脉有偶然的漂浮血栓。患者最初接受静脉注射肝素治疗,随后转为阿哌沙班治疗。尽管坚持服药,两周后她出现精神状态恶化和双腿肿胀。重复显像显示血栓破裂,导致右肾和肠梗死。抗凝失败的原因是她的减肥手术后继发的吸收不良。尽管进行了积极的干预,但患者最终发展为多系统器官衰竭,并死于疾病。文献表明,由于药代动力学的改变,DOACs对减肥后患者可能效果较差。由于缺乏针对减肥后患者的临床指南,我们推荐使用华法林(一种维生素K拮抗剂)进行全剂量抗凝治疗,以实现治疗性国际正常化比率(INR)监测和必要的剂量调整。doac在这一人群中效果较差,特别是在高凝状态下,缺乏监测增加了治疗失败和随后危及生命的并发症的风险。本病例报告是阿哌沙班治疗失败的女性患者Roux-en-Y胃旁路手术。学习要点:通过计算机断层扫描检测到的漂浮主动脉壁血栓没有确定的处理方法。减肥手术后口服抗凝剂的疗效尚不确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.10
自引率
0.00%
发文量
166
审稿时长
8 weeks
期刊介绍: The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信